Effect of vasopressin on type IV collagen production in human mesangial cells

Regulatory Peptides

Volumn 147, Issue 1-3, 2008, Pages 60-66

  Tahara, Atsuo ^a   Tsukada, Junko ^a   Tomura, Yuichi ^a   Suzuki, Takeshi ^a   Yatsu, Takeyuki ^a   Shibasaki, Masayuki ^a  

^a ASTELLAS PHARMA INC   (Japan)

Author keywords

Mesangial cells; Transforming growth factor ; Type IV collagen; V1A receptors; Vasopressin; YM218

Indexed keywords

COLLAGEN TYPE 4; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA ANTIBODY; UNCLASSIFIED DRUG; VASOPRESSIN; VASOPRESSIN ANTAGONIST; YM 218;

ARTICLE; CELL CULTURE; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HYPERTROPHY; MESANGIUM CELL; PRIORITY JOURNAL; PROTEIN SYNTHESIS;

BENZAZEPINES; CELLS, CULTURED; COLLAGEN TYPE IV; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MESANGIAL CELLS; PIPERIDINES; RECEPTORS, VASOPRESSIN; TRANSFORMING GROWTH FACTOR BETA; VASOPRESSINS;

EID: 40849135981     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2008.01.002     Document Type: Article

References (52)

1. Kashgarian M. Mesangium and glomerular disease. Lab Invest 52 (1988) 569-571
2. Mauer S.M., Steffes M.W., Ellis E.N., Sutherland D.E.R., Brown D.M., and Goetz F.C. Structural-functional relationships in diabetic nephropathy. J Clin Invest 74 (1984) 1143-1155
3. Striker L.J., Doi T., Elliot S., and Striker G.E. The contribution of glomerular mesangial cells to progressive glomerulosclerosis. Semin Nephrol 9 (1989) 318-328
4. Abrass C.K., Peterson C.V., and Raugi G.J. Phenotypic expression of collagen types in mesangial matrix of diabetic and non-diabetic rats. Diabetes 37 (1988) 1695-1702
5. Haralson M.A., Jacobson H.R., and Hoover R.L. Collagen polymorphism in cultured rat kidney mesangial cells. Lab Invest 57 (1987) 513-523
6. Foidart J.M., Foidart J.B., and Mahieu P.R. Synthesis of collagen and fibronectin by glomerular cells in culture. Renal Physiol 3 (1980) 183-190
7. Lovett D.H., Sterzel R.B., Kashgarian M., and Ryan J.L. Neutral proteinase activity produced in vitro by cells of glomerular mesangium. Kidney Int 23 (1983) 342-349
8. Kees-Forlts D., Mahan J.D., Mcallister C., Shannon B., and Cossio F.G. Fibronectin (FN) production in human glomerular cells. Kidney Int 33 (1988) 318
9. Suzuki Y., Matsui K., Oite T., Shimizu F., Koda Y., and Arakawa M. Localization of glomerular fibronectin in human and experimental glomerulonephritis. Jap J Nephrol 26 (1984) 263-273
10. Timpl R. Recent advances in the biochemistry of glomerular basement membrane. Kidney Int 30 (1986) 293-298
11. Raugi G.J., and Lovett D.H. Thrombospondin secretion by cultured human glomerular mesangial cells. Am J Pathol 129 (1987) 364-372
12. Wight T.N., Raugi G.J., Mumby S.M., and Bornstein P. Light microscopic immunolocation of thrombospondin in human tissue. J Histochem Cytochem 33 (1985) 295-302
13. Adler S. Structure-function relationships associated with extracellular matrix alternations in diabetic glomerulopathy. J Am Soc Nephrol 5 (1994) 1165-1172
14. Rosenblum N.D. The mesangial matrix in the normal and sclerotic glomerulus. Kidney Int 45 (1994) 73-77
15. MacKay K., Striker L.J., Stauffer J.W., Doi T., Agodoa L.Y., and Striker G.E. Transforming growth factor-β: Murine glomerular receptors and responses of isolated glomerular cells. J Clin Invest 83 (1989) 1160-1167
16. Ishimura E., Sterzel R.B., and Kashgarian M. Effect of transforming growth factor (TGF)-β on extracellular matrix (ECM) production by cultured rat mesangial cells. Kidney Int 37 (1990) 197
17. Ganz M.B., Pekar S.K., Perfetto M.C., and Sterzel R.B. Arginine vasopressin promotes growth of rat glomerular mesangial cells in culture. Am J Physiol 255 (1988) F898-F906
18. 2+. Am J Physiol 259 (1990) F269-F278
19. 1A receptor-selective antagonist, on human vasopressin and oxytocin receptors. Pharmacol Res 51 (2005) 275-281
20. Kasho M., Sakai M., Sasahara T., Anami Y., Matsumura T., Takemura T., et al. Serotonin enhances the production of type IV collagen by human mesangial cells. Kidney Int 54 (1998) 1083-1092
21. Foellmer H.G., Sterzel R.B., and Kashgarian M. Progressive glomerular sclerosis in experimental anti-glomerular basement membrane glomerulonephritis. Am J Kidney Dis 7 (1986) 5-11
22. Striker L.J., Killen P.D., Chi E., and Striker G.S. The composition of glomerular sclerosis. I. Studies in focal sclerosis, crescentic glomerulonephritis, and membranoproliferative glomerlonephritis. Lab Invest 51 (1984) 181-192
23. Striker L.J., Peten E.P., Plliot S.J., Doi T., and Striker G.E. Mesangial cell turnover: effect of heparin and peptide growth factors. Lab Invest 64 (1991) 446-456
24. Mene P., Simonson M.S., and Dunn M.J. Physiology of the mesangial cells. Physiol Rev 69 (1989) 1347-1424
25. Border W.A., Okuda S., and Nakamura T. Extracellular matrix and glomerular disease. Semin Nephrol 9 (1989) 307-317
26. Schor N., Ichikawa I., and Brenner B.M. Mechanisms of action of various hormones and vasoactive substances on glomerular ultrafiltration in the rat. Kidney Int 20 (1981) 442-451
27. Schondorff D. The glomerular mesangial cell: An expanding role for a specialized pericyte. FASEB J 1 (1987) 272-281
28. Ausiello D.A., Kreisberg J.I., Roy C., and Karnovsky M.J. Contraction of cultured rat glomerular cells of apparent mesangial origin after stimulation with angiotensin II and arginine vasopressin. J Clin Invest 65 (1980) 754-760
29. Kreisberg J.I., and Venkatachalam M.A. Vasoactive agents affect mesangial cell adhesion. Am J Physiol 251 (1986) C505-C511
30. Schulze-Lohoff E., Kohler M., Fees H., Reinld N., and Sterzel R.B. Divergent effects of arginine vasopressin and angiotensin II on proliferation and expression of the immediate early genes c-fos, c-jun and Egr-1 in cultured rat glomerular mesangial cells. J Hypertens 11 (1993) 127-134
31. Wolthuis A., Boes A., Rodemann H.P., and Grond J. Vasoactive agents affect growth and protein synthesis of cultured rat mesangial cells. Kidney Int 41 (1992) 124-131
32. Ikoma M., Kawamura T., Kakinuma Y., Fogo A., and Ichikawa I. Cause of variable therapeutic efficiency of angiotensin converting enzyme inhibitor on glomerular lesions. Kidney Int 40 (1991) 195-202
33. Egido J. Effects and interactions of endothelin-1 and angiotensin II on matrix protein expression and synthesis and mesangial cell growth. Hypertension 27 (1996) 885-892
34. Wolf G., Haberstroh U., and Neilson E.G. Angiotensin II stimulates the proliferation and biosynthesis of type I collagen in cultured murine mesangial cells. Am J Pathol 140 (1992) 95-107
35. Gomez-Garre D., Ruiz-Ortega M., Ortego M., Largo R., Lopez-Armada M.J., Plaza J.J., et al. Effects and interactions of endothelin-1 and angiotensin II on matrix protein expression and synthesis and mesangial cell growth. Hypertension 27 (1996) 885-892
36. Ichikawa I., and Harris R.C. Angiotensin actions in the kidney: renewed insight into the old hormone. Kidney Int 40 (1991) 583-596
37. Johnson R.L., Alpes C.E., Yoshimura A., Lombardi D., Pritzl P., Floege J., et al. Renal injury from angiotensin II-mediated hypertension. Hypertension 19 (1992) 464-474
38. Edwards R.M., Trizna W., and Kinter L.B. Renal microvascular effects of vasopressin and vasopressin antagonists. Am J Physiol 256 (1989) F274-F278
39. 1A receptor-selective antagonist, on vasopressin-induced growth responses in human mesangial cells. Eur J Pharmacol 538 (2006) 32-38
40. Brooks D.P., Nutting D.F., Crofton J.T., and Share L. Vasopressin in rats with genetic and streptozotocin-induced diabetes. Diabetes 38 (1989) 54-57
41. Fujisawa I., Murakami N., Furuto-Kato S., Araki N., and Konishi J. Plasma and neurohypophyseal content of vasopressin in diabetes mellitus. J Clin Endocrinol Metab 81 (1996) 2805-2809
42. Nishikawa T., Omura M., Iizuka T., Saito I., and Yoshida S. Short-term clinical trial of 1-(1-[4-(3-acetylaminopropoxy)-benzoyl]-4-piperidyl-3,4-dihydro-2(1H)-quinolinone in patients with diabetic nephropathy. Possible effectiveness of the specific vasopressin V1 receptor antagonist for reducing albuminuria in patients with non-insulin dependent diabetes mellitus. Arzneimitelforschung 46 (1996) 875-878
43. Abboud H.E., Poptic E., and DiCorleto P. Production of platelet-derived growth factor-like protein by rat mesangial cells in culture. J Clin Invest 80 (1987) 675-683
44. Border W.A., Okuda S., Languino L.R., and Ruoslahti E. Transforming growth factor-β regulates production of proteoglycans by mesangial cells. Kidney Int 37 (1990) 689-695
45. Baud L., Oudinet J.P., Bens M., Noe L., Peralki M.N., Rondeau E., et al. Production of tumor necrosis factor by rat mesangial cells in response to bacterial lipopolysaccharide. Kidney Int 35 (1989) 1111-1118
46. 2 and prostacyclin. Kidney Int 38 (1990) 232-239
47. 1-type receptor. Kidney Int 35 (1989) 1300-1305
48. Takuwa N., Ganz M., Takuwa Y., Sterzel R.B., and Rasmussen H. Studies of the mitogenic effect of serotonin in rat renal mesangial cells. Am J Physiol 257 (1989) F431-F439
49. Okuda S., Languino L.R., Ruoslahti E., and Border W.A. Elevated expression of transforming growth factor-β and proteoglycan production in experimental glomerulonephritis: possible role in expansion of the mesangial extracellular matrix. J Clin Invest 86 (1990) 453-462
50. Isaka Y., Fujiwara Y., Ueda N., Kaneda Y., Kamada T., and Imai E. Glomerulosclerosis induced by in vivo transfection of transforming growth factor-β or platelet-derived growth factor gene into the rat kidney. J Clin Invest 92 (1993) 2597-2601
51. Kaname S., Uchida S., Ogata E., and Kurokawa K. Autocrine secretion of transforming growth factor-β in cultured rat mesangial cells. Kidney Int 42 (1992) 1319-1327
52. Wakefield L.M., Smith D.M., Masui T., Harris C.C., and Sporn M.B. Distribution and modulation of the cellular receptor for transforming growth factor-beta. J Cell Biol 105 (1987) 965-975